Highlights, Trends, Opportunities & Outlook
Market Insight: Oded Ben-Joseph, PhD, Thomas Busby, Nick Frame, PhD, Elena Bonetti, Roisin O’Brien, PhD and Curtis Landry
Outcome Capital shares their analysis and insights on how artificial intelligence is impacting the BioPharma, Medical Devices and Diagnostics sectors.
Macroeconomic uncertainty, confusion surrounding the diagnostic regulatory landscape, and the continuing post-COVID-19 pandemic hangover have all contributed to a stagnant, quiet period for mergers and acquisitions in the in vitro diagnostics space in the first half of 2024.
Read MoreOutcome Capital Life Science Market Pulse June 2024 Click to view our LifeSciences Pulse Newsletter
DownloadWould you like to learn more about working with Outcome Capital or discuss your specific needs?